Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
WASHINGTON, Jan 8 (Reuters) - The U.S. Supreme Court on Monday denied a bid by Intel (INTC.O) and Edwards Lifesciences (EW.N) to revive part of their lawsuit challenging a U.S. Patent and Trademark
Feb 16 (Reuters) - A U.S. appeals court on Friday revived a patent lawsuit against Comcast (CMCSA.O), over voice-recognition technology for television systems. The U.S. Court of Appeals for the
subsidiaries and BMW in the appeal proceedings. The company later withdrew the claims against the Munich-based car manufacturer and others. Brose had filed a nullity suit against patent DE 041 with
March 25 (Reuters) - Singapore-based Maxeon Solar (MAXN.O) said on Monday it had initiated a patent infringement lawsuit against solar technology firm Canadian Solar (CSIQ.O) in the Eastern District
AlloSeq kidney-transplant tests infringe a Natera patent, according to a verdict made public on Monday. The jury determined, that Natera was entitled to more than $83.6 million in lost profits and $12.6
violating its patent rights in road-building technology. The jury determined that Caterpillar's road-milling machines, which remove the surfaces of roads before repaving them, infringe five Wirtgen
March 1 (Reuters) - A jury in Delaware federal court said on Friday that Midwest Energy Emissions Corp (MEEC.PK), (ME2C), which specializes in reducing mercury emissions from coal-fired power plants, ...
Beach, Florida-based Chewy sued IBM in 2021, seeking a judgment that it did not infringe IBM's patents after it rejected a $36 million IBM patent licensing offer. Chewy accused IBM of seeking
Mutiple pharmaceutical companies have succeeded in revoking a blockbuster Bayer patent in the latest round of proceedings, which have this time taken place in London. The ruling paves the way for
women at high risk of fracture, brought in total third-quarter sales of $986 million. The drug is set to lose its U.S. patent in February next year. Several other drugs, which treat bone loss or
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
